Cerus (CERS) Net Cash Flow (QoQ) (2010 - 2026)
Cerus (CERS) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.11% |
| Dec 31, 2025 | 1,546.95% |
| Sep 30, 2025 | 92.85% |
| Jun 30, 2025 | -280.87% |
| Mar 31, 2025 | 40.29% |
| Dec 31, 2024 | -118.01% |
| Sep 30, 2024 | 210.33% |
| Jun 30, 2024 | -190.44% |
| Mar 31, 2024 | 255.01% |
| Dec 31, 2023 | -82.92% |
| Sep 30, 2023 | 53.77% |
| Jun 30, 2023 | 15.40% |
| Mar 31, 2023 | -232.89% |
| Dec 31, 2022 | 300.13% |
| Sep 30, 2022 | 45.89% |
| Jun 30, 2022 | 45.90% |
| Mar 31, 2022 | 64.69% |
| Dec 31, 2021 | -249.10% |
| Sep 30, 2021 | 1,393.41% |
| Jun 30, 2021 | -93.83% |